New requirements drive greater price transparency in the new year
We are excited to present this article, reprinted with permission from Ryan Hess, Vice President of Product Innovation at Surescripts®. At the end of 2020, Congress passed legislation intended to drive greater price transparency for prescription medication. Part D Medicare plans … Continue reading →





